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Abstract
Background: Cell-to-cell virus transmission of Human immunodeficiency virus type-1 (HIV-1) is predominantly mediated by
cellular structures such as the virological synapse (VS). The VS formed between an HIV-1-infected T cell and a target T cell
shares features with the immunological synapse (IS). We have previously identified the human homologue of the Drosophila
Discs Large (Dlg1) protein as a new cellular partner for the HIV-1 Gag protein and a negative regulator of HIV-1 infectivity.
Dlg1, a scaffolding protein plays a key role in clustering protein complexes in the plasma membrane at cellular contacts. It is
implicated in IS formation and T cell signaling, but its role in HIV-1 cell-to-cell transmission was not studied before.
Methodology/Principal Findings: Kinetics of HIV-1 infection in Dlg1-depleted Jurkat T cells show that Dlg1 modulates the
replication of HIV-1. Single-cycle infectivity tests show that this modulation does not take place during early steps of the
HIV-1 life cycle. Immunofluorescence studies of Dlg1-depleted Jurkat T cells show that while Dlg1 depletion affects IS
formation, it does not affect HIV-1-induced VS formation. Co-culture assays and quantitative cell-to-cell HIV-1 transfer
analyses show that Dlg1 depletion does not modify transfer of HIV-1 material from infected to target T cells, or HIV-1
transmission leading to productive infection via cell contact. Dlg1 depletion results in increased virus yield and infectivity of
the viral particles produced. Particles with increased infectivity present an increase in their cholesterol content and during
the first hours of T cell infection these particles induce higher accumulation of total HIV-1 DNA.
Conclusion: Despite its role in the IS formation, Dlg1 does not affect the VS and cell-to-cell spread of HIV-1, but plays a role
in HIV-1 cell-free virus transmission. We propose that the effect of Dlg1 on HIV-1 infectivity is at the stage of virus entry.
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Introduction
Retrovirus spread depends on the correct assembly, budding
and transmission of viral particles both by cell-free viral particles
and by virus cell-to-cell transfer. Human immunodeficiency virus type-1
(HIV-1) cell-to-cell virus transmission is known to be more efficient
than cell-free virus transmission [1,2,3,4] and the former mode of
transmission is probably predominant in vivo between cells close to
each other, in tissues where primary infection occurs. Cell-to-cell
viral transmission is mediated by cellular structures that allow the
movement of HIV-1 between cells, such as membrane nanotubes
[5], filopods [6] and the stable macromolecular adhesive contact
known as virological synapse (VS). The VS forms a tight cleft
between an infected cell and a target cell [7,8,9,10,11] and appears
to be the dominant structure involved in cell-to-cell spread of
HIV-1 in T cells [12,13]. VS formation is initiated by the
interaction between the viral envelope glycoprotein Env on the
surface of the infected cell and the cellular receptor CD4 and the
co-receptors CXCR4 or CCR5 on the target cell. This cellular
conjugate is stabilized by the adhesion molecule lymphocyte
function-associated antigen 1 (LFA-1) together with talin and actin
on the target cell [7,8] and the intracellular adhesion molecule 1
(ICAM-1), which interacts with LFA-1, on the infected cell [13].
The VS shares features and components with the immunological
synapse (IS), the cellular conjugate formed between a T cell and an
antigen-presenting cell (APC). The IS is formed by recognition
between the T cell receptor (TCR) on the T cell and the cognate
peptide-major histocompatibility complex (pMHC) on the APC.
Importantly, it was reported that HIV-1 infection impairs the
formation of the IS [14].
Maximum efficiency of virus assembly, budding and transmis-
sion of HIV-1 depend on the host cell machinery recruited by the
viral protein Gag that interacts with numerous host proteins,
complexes and structures [15,16,17]. We previously identified the
human homologue of Drosophila Discs Large (Dlg1) protein as a
new cellular partner of HIV-1 Gag and described Dlg1 as a nega-
tive regulator of virus particle infectivity [18]. In Dlg1-depleted
cells, Gag production and maturation or virus release were not
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infectious [18].
Dlg1 is a membrane-associated guanylate kinase (MAGUK), it
is an important adaptor protein involved in the assembly of protein
complexes at sites of cell-to-cell contact. Dlg1 is a modular protein
consisting of a proline-rich N-terminal region, multiple PDZ
(PSD-95–DLG–ZO-1) domains, a Src homology 3 domain, a
HOOK (protein 4.1 binding) domain and a GUK-like domain.
Dlg1 is a scaffolding protein recruited beneath the plasma mem-
brane at cellular contacts such as synapses, adherent junctions and
tight junctions, where it plays a key role in clustering protein
complexes. It is implicated in T cell signaling, polarity [19],
morphology and migration, and in IS formation [20]. In T cells,
Dlg1 interacts with the cellular surface proteins, PTA-1, Kv1.3,
CD2, and with LFA-1 and it localizes transiently in the IS upon
antigen presentation [21]. Dlg1 recruited to the IS interacts with
key components of T cell signaling [20,22,23], it may link the
TCR signaling machinery with regulators of the cytoskeleton.
Dlg1 is thought to be involved in coordinating T cell activation
and actin polymerization induced by the lymphocyte-specific
protein tyrosine kinase (Lck) and mediated by the Wiskott–Aldrich
syndrome protein, required for synaptic lipid raft and TCR
clustering [24]. In Jurkat T cells, Dlg1 was reported to be an
activation antagonist that would promote receptor internalization
after initial TCR engagement [21]. It was also shown in Jurkat T
cells that Dlg1 and ezrin cooperate to control IS architecture and
T cell activation [25]. In addition, it was reported that Dlg1
interacts with the Zeta-chain-associated protein kinase 70 kDa
(Zap70) involved in the IS [26,27] and that Zap70 in donor HIV-
1-infected cells was involved in HIV-1 cell-to-cell transmission
[28].
Although it is clear that Dlg1 plays a key role in T cells by
organizing signaling complexes at the IS, its role in the VS or in
cell-to-cell virus transmission has not been studied. Given these key
roles of Dlg1, we expected that it could affect VS formation and/
or HIV-1 cell-to-cell transmission. In this study the possible
implication of Dlg1 in HIV-1 infection of a natural target of the
virus was investigated in T cells depleted of Dlg1. We demonstrate
for the first time that despite the key role of Dlg1 in the IS
formation and T cell signaling, Dlg1 does not affect VS formation
or cell-to-cell spread of HIV-1. Our results show a specific role
of Dlg1 in HIV-1 cell-free virus transmission and allow us to
postulate that by modifying viral cholesterol content Dlg1 affects
the step of virus-cell fusion.
Materials and Methods
Cells and cell culture
CD4+/CXCR4+ Jurkat T cells (clone 20; a kind gift of Dr.
Olivier Schwatz, Institut Pasteur, Paris, France), APC (Raji B cells;
a kind gift of Dr. Georges Bismuth, Institut Cochin, Paris, France)
and Jurkat LTR-luciferase T cells (1G5 cells; AIDS Research and
Reference Reagent Program) were maintained in complete RPMI
medium: RPMI 1640 (Gibco) supplemented with 10% FCS,
streptomycin (100 mg/mL; Gibco), penicillin (100 U/mL; Gibco),
glucose (0.43%, Gibco) and glutamine (2 mM; Gibco). Peripheral
blood mononuclear cells (PBMCs) were isolated from whole blood
or buffy coats (E ´tablissement Franc ¸ais du Sang, St Vincent de
Paul, Paris, France) by Ficoll-Hypaque (Sigma) gradient centrifu-
gation. Primary CD4+ T cells were purified by negative selection
with a CD4+ T cell enrichment kit (Human CD4 T lymphocyte
enrichment set-DM, BD Biosciences) according to the manufac-
turer’s protocol. The primary CD4+ T cells were first activated
with phytohemaglutinin A (PHA-L; 3.0 mg/mL; Sigma-Aldrich)
and interleukin-2 (IL2; 50 IU/mL; PeproTech) then maintained
in culture with IL2 (50 IU/mL). 293T and HeLa P4.2 cells (Hela-
CD4-HIV-LTR-lacZ cells) were maintained in DMEM medium
(Gibco) supplemented with 10% FCS, streptomycin (100 mg/mL),
penicillin (100 U/mL) and glutamine (2 mM).
Antibodies
Primary antibodies used to detect the HIV-1 envelope protein
on immunoblots were the anti-gp120 goat polyclonal (1/10000;
Abcam) and the monoclonal antibody (mAb) anti-Env 5F7 (1/200;
AIDS Research and Reference Reagent Program) [29]. Other
primary antibodies used on immunoblots were: the HIV-1 anti-
CA-p24 #24-2 mAb for HIV-1 Gag (1/5000; AIDS Research and
Reference Reagent Program), the anti-tubulin mAb (1/5000;
Sigma-Aldrich) for tubulin, the anti-GAPDH 6C5 mAb (1/1000;
Santa Cruz Biotechnology) for GAPDH. The anti-PSD-95 mAb
(PDZ domain; US Biological) was used for detection of Dlg1 on
immunoblots (1/2500) and by immunofluorescence (IF; 1/100).
Other primary antibodies used for IF were the HIV-1SFE p24
rabbit antiserum (1/5000; AIDS Research and Reference Reagent
Program) for Gag, the anti-CD4 mAb MAB379 (1/50; R&D
systems) for the CD4 receptor. The anti-pericentrin rabbit
polyclonal antibodies (1/2500; Abcam) were used to visualize
the microtubule organizing center (MTOC) by IF and the 4G10
mAb (1/2; Ubi) for phosphotyrosine. Primary antibodies were
detected with Cy3-, Cy5-, Alexa 568-, or Alexa 647-conjugated
goat anti-mouse (1/500; Invitrogen), goat anti-rabbit (1/500;
Invitrogen), donkey anti-mouse (1/2000; Invitrogen), or donkey
anti-rabbit (1/2000; Invitrogen) secondary antibodies.
The anti-CD3-phycoerythrin (PE; 1/100; BD Pharmingen),
anti-LFA-1 (1/20; Thermo Scientific), anti-CD4-PE (1/20; Beck-
man Coulter), anti-Human CD54-biotin (anti ICAM-1; 1/100;
eBioscience), anti-CXCR4 12G5 mAb (1/100; AIDS Research
and Reference Reagent Program) [30] and anti-Env 5F7 (1/20)
were used to detect CD3, LFA-1, CD4, ICAM-1, CXCR4 and
HIV-1 Env respectively by flow cytometry. PE-conjugated
secondary antibodies (1/200; Dako) or PE-conjugated streptavidin
(1/1000; eBioscience) were used when necessary. For intracellular
Gag measurements the anti-HIV-p24 KC57-PE mAb (1/500;
Coulter Beckman) was used.
Plasmids
The HIV-1 proviral clones pNL4-3 and LAI.2 were obtained
from the NIH AIDS Research and Reference Reagent Program.
The luciferase-expressing vector pNLuc [31] and the envelope
protein expression vector pIIINL4env [32] were kind gifts from
Dr. Eric Freed (NIH). The control siRNA [33] and the siRNA
directed to the N-terminal domain specific for Dlg1 (nucleotides
569 to 587: 59UGAAGUGAUAGGUCCAGAA39; accession no.
NM_004087) were obtained from QIAGEN (Courtaboeuf,
France). The lentiviral vector pHIV-H1shRNADlg1 (pV2.3.60;
generated by Vectalys, Labe `ge, France) encodes the GFP gene and
a short hairpin RNA (shRNA) directed against Dlg1 for its
depletion (same sequence as for siRNA, nucleotides 569 to 587).
The siRNA and shRNA specifically target the seven known
isoforms (splicing variants; http://www.uniprot.org/uniprot/
Q12959#section_comments) of human Dlg1, but not the other
members of the Dlg family of MAGUKs [34]. The control
lentiviral vector pshRNACtl encodes the GFP gene and an
irrelevant shRNA control sequence. The lentiviral vector Mission
shRNADlg1 (NM_004087; Sigma) encodes the puromycin
resistance gene and an shRNA sequence for Dlg1 depletion
(59CCGGGCACAGATGCAGATTATGAATCTCGAGATTC-
ATAATCTGCATCTGTGCTTTTT39). The control lentiviral
Dlg1 in VS Formation and HIV-1 Transmission
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and an irrelevant shRNA sequence.
Transduction, transfection and infection
Jurkat T cells were transduced with one of the lentiviral vectors
in the presence of 10 mM Hepes and 2 mg/mL DEAE to improve
transduction. The stable Dlg1-depleted T cell lines were obtained
using the following lentivirus-based vectors. The GFP-encoding
lentiviral vectors pHIV-H1shRNADlg1 and pshRNACtl were
used to obtain stably transduced Jurkat cells depleted of Dlg1
(referred to as Dlg1-) or control cell lines expressing endogenous
Dlg1 (referred to as Dlg1+) respectively. After 3 h incubation at
37uC, complete fresh RPMI medium was added. Cells transduced
with the GFP-encoding pHIV-H1shRNADlg1 or shRNACtl
vectors were cultured for at least a week at 37uC before sorting
the Dlg+ and Dlg1- cells for GFP positive cells by flow cytometry.
Cells transduced with the puromycin-encoding Mission shRNA
vectors were cultured for three days without selection and there-
after in RPMI supplemented with puromycin (0.75 mM/mL;
Gibco).
The X4 NL4.3 and LAI.2 strains of HIV-1 were produced in
293T cells (1.5610
6) transfected with 5 mg of pNL4.3 or LAI.2
proviral plasmids by the calcium phosphate technique and
supernatants of cultured cells were collected 48 to 72 h post-
transfection. For the production of HIV-1 in 293T cells depleted
of Dlg1 by siRNA, two successive transfections were performed on
1.5610
6 cells. The first transfection was with 20 nM siRNA and
the second one 24 h later, with the same amount of siRNA
together with 5 mg of LAI.2 proviral plasmid. Viruses were then
filtered through a 0.45 mm pore-size filter and assayed for p24
content with the ELISA INNOTEST HIV Antigen mAb
(INGEN). T cell lines were infected with HIV-1 NL4.3 at a
multiplicity of infection (MOI) of 0.005 to 0.05 in small volumes
(100 to 500 mL) of RPMI medium containing 10 mM Hepes and
2 mg/mL DEAE to improve viral adhesion. RPMI alone was used
for infections in which the properties of viral particles produced by
Dlg1+ or Dlg1- cells were compared. After 2 h incubation at 37uC
the viral inoculum was washed off with complete RPMI medium
and the cells were maintained in culture at 37uC.
Kinetics of infection were followed by determining the fraction
of HIV-1-infected cells in the T cell cultures measuring intra-
cellular Gag by flow cytometry. Cells were fixed, permeabilized (as
described for immunofluorescence) and stained with the anti-HIV-
p24 KC57-PE mAb which recognizes the 55, 39, 33 and 24 kDa
proteins of the core of HIV-1.
Single cycle pseudotyped virions were produced in 293T cells
by co-transfecting, as described above, 5 mg of the luciferase-
expressing vector pNLuc with 0.5, 0.75 or 1 mg of the HIV-1
envelope-expressing vector pIIINL4env or with 50 ng of the
plasmid encoding the Vesicular stomatitis virus glycoprotein G (VSV-
G). The pseudotyped virions were normalized for p24 and used to
infect Dlg1 + or Dlg1- Jurkat T cells. A range of viral input from
100 to 1000 ng of p24 was used to infect Dlg1+ and Dlg1- Jurkat
T cells as described above. Two dpi, the cells were lysed and
luciferase activity was determined.
Quantification of HIV-1 total DNA
HIV-1 NL4.3 and LAI.2 viral stocks produced by cells
expressing or not Dlg1 were treated with 3 IU of Dnase I
(Qiagen) per mg of p24 for 1 h at 37uC before infection of 2610
6
Jurkat cells in RPMI as described above. Cells were harvested 6 h
later, washed three times in PBS (Gibco) and DNA was extracted
using the QIAamp Blood DNA minikit (Qiagen). Quantification of
viral DNA was performed in triplicate by quantitative PCR on a
Light Cycler 480 instrument (Roche Diagnostics, Meylan, France)
using the Light Cycler 480 probe master (Roche Diagnostics) and
the previously described HIV-1-specific primers and fluorogenic
probes [35]. The forward primer MH531 anneals to the U5 region
of the LTR (59TGTGTGCCCGTCTGTTGTGT39), the reverse
primer MH532-NL4.3 anneals to the upstream region of gag (59G-
AGTCCTGCGTCGAGAGATC39) and the fluorogenic probes
for these region are MHFL: 59CCCTCAGACCCTTTTAGT-
CAGTGTGGAA-fluorescein and MHLC: 59 LC640TCTCTAG-
CAGTGGCGCCCGAACAG-PH. After an initial denaturation
step (95uC for 8 min), 40 cycles consisting of 95uC for 10 s, 60uC
for 10 s and 72uC for 6 s were performed. The second-derivative-
maximum method provided by the Light Cycler SW 1.5 quan-
tification software was used (Roche Diagnostics). The reference
gene was human ß-globin, amplified using the Light Cycler con-
trol kit DNA (Roche Diagnostics) that includes human genomic
DNA and ß-globin-specific primers and probes. Viral DNA
quantification was determined using the DCq method [36]. For
each HIV-1 DNA and globin, the mean Cq of all samples was
used to calculate the DCq. The calculations performed for all the
values were: the DCq = the mean Cq – each Cq, the RQ =
Efficiency of gene’s amplification
DCq and the normalized NRQ =
RQ HIV-1 DNA/RQ globin.
Infectivity tests and particle analysis
Supernatants of Dlg1+ and Dlg1- Jurkat T cells infected with
HIV NL4.3 at a multiplicity of infection (MOI) of 0.05 were
collected 7 days post-infection (dpi). Equal amounts of virus
(from 1 to 5 ng) determined either by p24 content or by reverse
transcriptase (RT) activity (quantified by the Quan-T-RT assay
system, Amersham Bioscience) were used to infect HeLa P4.2
reporter cells. After 36 h of incubation, the cells were lysed and b-
galactosidase production was assessed by a colorimetric assay
based on cleavage of chlorophenol red-ß-D-galactopyranoside
(CPRG) as described previously [18]. The mean optical density
value of four experiments obtained from extracts of cells infected
with viruses from Dlg1+ Jurkat T cells was taken as 100%.
Single-cycle infectivity analyses were performed by using HIV-1
pseudotypes obtained with the pNLuc [31] vector together with
the HIV-1 Env expression vector pIIINL4env [32] to determine
the efficiency of early steps of the HIV-1 life cycle in cells
expressing or not Dlg1. Cells were lysed 48 h post-infection and
luciferase activity was measured using the luciferase assay reporter
kit (Promega) according to the manufacturer’s instructions.
Purified virions were obtained from supernatants of infected
cultures, filtered (0.45 mm) and ultracentrifuged through a 25%
sucrose cushion in TNE buffer (100 mM NaCl, 10 mM Tris-HCl,
pH 7.4, and 1 mM EDTA). Ultracentrifugation was performed at
150000 X g for 1 h at 4uC in a Beckman SW41 Ti rotor and viral
pellets were resuspended in 30 mL lysis buffer (20 mM Tris-HCl
pH 8, 0.2 mM EGTA, 120 mM NaCl, 0.2 mM NaF, 0.2%
Sodium deoxycholate, 0.5% NP40, and complete protease
inhibitors; Roche Applied Science) before immunoblotting.
Determination of viral cholesterol content
HIV-1 LAI.2 virions were recovered, ultracentrifuged and
solubilized as described above, and were normalized according to
their p24 content to determine their cholesterol content using the
Amplex Red Cholesterol Assay Kit (Invitrogen) according to the
manufacturer’s protocol. The media from uninfected cells were
prepared the same way as the virions and were used as controls in
the cholesterol assay to evaluate contaminating cholesterol not
associated to virions.
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To quantify HIV-1 transfer from infected to target cells an
adaptation of the co-culture assay reported by Sourisseau et al. [2]
was used. Dlg1+ or Dlg1- Jurkat T cells were infected with HIV-1
NL4.3 at an MOI of 0.005 or 0.05. Once the cultures had reached
a minimum of 20% infection, infected (Gag+/GFP+) cells were co-
cultivated at a 1:1 ratio for up to 17 h with target uninfected Jurkat
cells (GFP-) or with primary CD4+ T cells stained with cell trace
violet (Invitrogen). Samples were collected and analyzed for Gag
transfer into target cells at different time points of the co-culture by
intracellular Gag staining with KC57-PE mAb followed by flow
cytometry analysis (Canto 2 cytometer or FC-500 Cytomics).
This co-culture test was also adapted to measure productive
HIV-1 transmission into the target cells. Dlg1+ or Dlg1- Jurkat T
cells infected as described above were co-cultivated at a ratio of 1:1
with uninfected Jurkat LTR-luciferase cells (1G5 cells) for 24 h.
Luciferase activity was then measured in target 1G5 cells after lysis
using the Promega luciferase kit, according to the manufacturer’s
instructions.
Immunofluorescence and laser scanning confocal
microscopy
HIV-1-infected Dlg1+ and Dlg1- Jurkat T cells, 5 to 7 dpi when
cultures showed at least 50% Gag positive cells were allowed to
form contacts. Infected cells (500 000 cells) were mixed at a 1:1
ratio with target uninfected primary CD4+ T cells and deposited
for an hour at 37uC on poly-L-Lysine-coated coverslips to allow
contact formation. For intracellular staining, cells were fixed with
4% paraformaldehyde, permeabilized with methanol and washed
with PBS buffer containing 2% BSA and 0.1% Tween 20. The
cells were fixed and permeabilized to label internal Gag, Dlg1, and
CD4 (with the blocking antibody MAB379) after VS formation.
The cells were then incubated 40 min at room temperature with
the primary antibodies anti-p24, anti-PSD-95 or anti-CD4 diluted
in PBS buffer containing 2% BSA and 0.1% Tween 20. Primary
antibodies were detected with Cy3-, or Cy5-conjugated goat anti-
mouse, and anti-rabbit secondary antibodies. Monosynapses were
defined as single cell-to-cell contacts presenting enrichment of Gag
on the infected cell and co-localization with CD4 on the CD4+
target cell at sites of contact. Polysynapses were defined as contacts
between a single effector cell and multiple target cells.
For the visualization of MTOC polarization, IS conjugates were
formed between Jurkat and APC (Raji B) cells. Phosphotyrosine
accumulation at the interface between the two cells was used as a
marker of a productive IS contact that has led to TCR activation
and to activation of the downstream signaling cascade. Centrin
was used simultaneously to localize the MTOC. APCs were pulsed
with 200 ng/mL superantigen in serum-free RPMI 1640 and
plated on coverslips for 30 min at 37uC. Superantigen was a mix
of recombinant staphylococcal enterotoxin E, A, B, and C3 (Toxin
Technology). Dlg1+ or Dlg1- Jurkat cells were loaded with
Hoechst and added to the APCs for 14 min at 37uC to allow
conjugate formation. Cells were fixed with 2% paraformaldehyde
for 10 min at room temperature and washed with PBS containing
0.5% BSA and 0.1% saponin. The cells were then incubated with
the primary antibodies anti-pericentrin and anti-phosphotyrosine
for 30 min. Primary antibodies were detected with Alexa 568-, or
Alexa 647-conjugated donkey anti-mouse or donkey anti-rabbit
secondary antibodies.
Coverslips were mounted with Fluorsave reagent (Calbiochem)
or the ProLong anti-fade kit solution (Invitrogen). Laser scanning
microscopy was performed using a Leica TCS resonant scanner
multi-photon (spinning disc) or a Leica TCS SP2 AOBS, with the
63X objectives. Epifluorescence images were acquired with a
Nikon TE2000, a CCD 16 Bits camera (Cascade, Princeton
Instruments) and the Metamorph software (Molecular Devices).
Images were analyzed using ImageJ software (Wayne Rasband;
NIH). For quantitative image analysis of MTOC polarization at
the IS, a conjugate was defined as a contact between a Jurkat and
an APC with phosphotyrosine accumulation at the IS. The ratio
between the distance from the MTOC to the IS and the cell
diameter were calculated. The MTOC was considered relocalized
if the ratio was inferior to the threshold value of 20%.
Electron Microscopy
Dlg1+ and Dlg1- HIV-1-infected Jurkat cells (3.10
6) six or seven
days post-infection, when the cultures showed at least 60% Gag+
cells, were fixed for 4 h in a solution containing 2% paraformal-
dehyde, 2.5% glutaraldehyde and 2.5% sucrose. The cells were
washed in PBS and centrifuged at 20000 X g. Subsequently, the
cellular pellet was washed three times in 0.1 M sodium phosphate
buffer pH 7.0, incubated 30 min at 4uC in osmic acid (1% in
sodium phosphate buffer) and dehydrated in graded ethanol
solutions (2x10 min in 70%, 2x10 min in 90% and 2x10 min in
100% ethanol). The cell pellet was then incubated 2x1 min in
propylene oxide, 10 min in 50% Epon-50% propylene oxide, then
embedded in Epon and incubated for polymerization 24 h at
60uC. Finally, 90 nm sections were cut on a Reichert Ultracut S
and layed on a grid for 10 min of staining with 2% uranyl acetate
and 4 min with lead citrate at room temperature. The observa-
tions were performed with a JEOL 1011 transmission electron
microscope and the images recorded at 80 kv with a GATAN
Erlangshen camera 1000. For quantifications a total of 5300
Dlg1+ Jurkat T cells and of 6500 Dlg1- Jurkat T cells were
observed.
Statistical analysis
Statistical analyses were performed using the Mann Whitney
and chi
2 tests. Statistical significance was defined for P values
,0.05.
Results
Kinetics of HIV-1 replication in Dlg1-depleted T cells
To establish an experimental system that allows kinetic studies
of HIV-1 infection in a natural host cell of the virus, Jurkat T cells
were stably depleted of Dlg1 and infected by HIV-1. This system is
physiologically more relevant than the one used previously with
adherent 293T cells depleted of Dlg1 by siRNA and transfected
with a proviral HIV-1 plasmid [18]. The stable Dlg1-depleted
Jurkat T cell lines (Dlg1-) were obtained using two lentivirus-based
vectors that target two different sequences in Dlg1 indicated in the
materials and methods section. The depletion of Dlg1 obtained in
Dlg1- Jurkat T cells using the GFP-encoding pHIV-H1shRNA
lentivirus was 85% compared to Dlg1 control (Dlg1+) Jurkat T cell
levels (Figure 1A). The depletion of Dlg1 obtained using the
puromycin-encoding Mission shRNADlg1 lentivirus in Dlg1-
Jurkat T cells was 95% compared to control Dlg1+ Jurkat T cell
levels (Figure 1A).
Given the key role of Dlg1 in clustering protein complexes at the
plasma membrane, in T cell signaling and in IS formation, the
Dlg1- T cells were characterized to determine if the absence of
Dlg1 affects the expression of surface molecules that are parti-
cularly important for T cell function and for HIV infection. The
surface level of receptors that are components of the IS (CD3,
LFA-1, ICAM-1), or the VS (CD4, LFA-1) and the viral receptor/
co-receptor (CD4, CXCR4) were determined by flow cytometry
after staining with specific antibodies. The surface levels of CD3,
Dlg1 in VS Formation and HIV-1 Transmission
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Dlg1+ cells (Figure 1B), indicating that Dlg1 knock down does not
have a general deleterious effect.
The course of HIV-1 replication during infection was followed
in Dlg1+ and Dlg1- Jurkat T cells infected with the NL4.3 HIV
strain by measuring intracellular Gag by flow cytometry. The
propagation of the virus was more efficient in Dlg1- cells, with
40% more infected cells seven days-post infection (dpi), indicating
that Dlg1 affects the replication of HIV-1 in T cells (Figure 1C).
We wondered whether the increase in HIV-1 replication was
due to an effect of Dlg1 in either early or late steps of the virus life
cycle. To this end, the efficiency of early steps of the HIV-1 life
cycle in cells expressing or not Dlg1 was determined by using
single-cycle HIV-1 infectivity assays in the absence of virus spread.
The pNL4.3-derived pNluc vector, which is Envelope and Nef
minus and expresses luciferase following infection [31], together
with the HIV-1 Env expression vector pIIINL4env [32] were used
to produce pseudotyped viruses. Within the range of viral inputs
tested from 100 to 1000 ng of p24, no difference in the levels of
luciferase activity was observed between cells expressing or not
Dlg1 (Figure 1D). These results suggest that Dlg1 does not
interfere with early steps of HIV-1 life cycle, therefore it may affect
late steps of the virus life cycle such as virus assembly, budding,
cell-free virus transmission or cell-to-cell transmission.
Virological synapse formation in Dlg1-depleted T cells
The Dlg1- T cells were functionally characterized by looking at
the MTOC polarization during IS formation between T cells and
APCs. In T cells, MTOC polarization to the plasma membrane
modulates IS formation and T cell signaling [37,38] and Dlg1
Figure 1. HIV-1 replication is enhanced in Dlg1-depleted T cells. A. Dlg1 expression in Dlg1+ and Dlg1- Jurkat T cells obtained with
two lentivirus-based shRNA vectors. The stable Dlg1-depleted Jurkat T cell lines (Dlg1-) were obtained using two lentivirus-based vectors that
target two different sequences on Dlg1. Control Jurkat T cell lines (Dlg1+) were obtained using the control vectors. T cells transduced with the GFP-
encoding vectors (pHIV-H1shRNADlg1 or pHIV-H1shRNACtl) or with the puromycin-encoding vectors (Mission shRNADlg1 or Mission shRNA Ctl) were
analyzed by western blot, and Dlg1 levels were quantified using ImageJ software. B. Expression of surface molecules in Dlg1+ and Dlg1-
Jurkat T cells. Cells were labeled with antibodies against CD3, CD4, CXCR4, LFA-1 and ICAM-1 and analyzed by flow cytometry. The data are
representative of three independent experiments performed in triplicates. For LFA-1 the mean values of three independent experiments performed
in triplicates is also presented. C. HIV-1 replication in Dlg1+ and Dlg1- Jurkat T cells infected with the NL4.3 HIV strain. Viral replication
was measured by determining the fraction of HIV-1-infected cells in the two cultures by intracellular Gag labeling and flow cytometry. Cells were
labeled with the anti-HIV-p24 mAb KC57-PE, 3, 5 and 7 dpi. The data are the means of four independent experiments performed in duplicate.
P=0.031 for 5 dpi. P,0.0001 for 7 dpi. D. Efficiency of early steps of the HIV-1 life cycle in cells expressing or not Dlg1. Dlg1+ and Dlg1-
Jurkat T cells were infected with the single cycle pNL4.3-derived pNluc vector pseudotyped with the HIV-1 Env expression vector pIIINL4env and
luciferase activity was measured 48 h post infection. The data are the means of three independent experiments performed in triplicate, using 100 ng
to 1000 ng of p24 of virus produced by 293T cells co-transfected with 5 mg of pNLuc and 0.5, 0.75 or 1 mg of pIIINL4env. P=0.59. Error bars represent
standard error of the mean (SEM). ns = no statistically significant difference. *, P,0.05. ***, P,0.001. AU = arbitrary units.
doi:10.1371/journal.pone.0030130.g001
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osine accumulation at the interface between the conjugated cells
was used as a marker of a productive IS contact that has led to
TCR activation and to activation of the downstream signaling
cascade. Centrin was visualized simultaneously to localize the
MTOC. Figure 2A shows results obtained with the pHIV-
H1shRNADlg1 and pHIV-H1shRNACtl vectors expressing the
GFP. As expected, MTOC polarization towards the plasma
membrane during IS formation was reduced in Dlg1- cells. An
example of a polarized MTOC in Dlg1+ cells and of a non-
polarized MTOC in Dlg1- cells are depicted (Figure 2A left panel).
The quantification of MTOC polarization in Dlg1+ and Dlg1-
cells (Figure 2A right panel) shows a statistically significant
reduction of MTOC polarization towards the plasma membrane
during IS formation in Dlg1- cells. Therefore, these cells can be
used to further study the possible role of Dlg1 in VS formation and
virus transmission during HIV-1 infection.
To determine the cellular localization of Gag in the presence
and absence of Dlg1, HIV-1-infected Dlg1+ and Dlg1- T cells
were immunostained for Dlg1 and Gag. Dlg1 is present at the
cellular periphery and particularly at cell contacts in Dlg1+ cells
and no Dlg1 was observed in Dlg1- cells (Figure 2B). Gag is at the
cellular periphery and accumulates at cell contacts between
infected and target cells in both Dlg1+ and Dlg1- cells as indicated
by white arrows (Figure 2B and C).
Jolly et al. [7] described HIV-1-induced VS formation as the
coenrichment of the viral Gag and Env proteins on the infected
cell and of CD4 on the primary target cell at sites of cell-to-cell
contact. Monosynapses were scored here as single cell-to-cell
contacts presenting enrichment of Gag on the HIV-1-infected cell
and colocalization with CD4 on the target cell at sites of contact.
Polysynapses were defined as contacts between a single effector cell
and multiple target cells. Using these criteria, virological mono-
synapses and polysynapses formed between donor Dlg1+ or Dlg1-
cells and Jurkat target T cells appeared similar (data not shown).
Since the mAb used for these studies is a CD4 blocking mAb,
staining of permeabilized CD4+ primary cells allowed the
detection of CD4 not bound to gp120 and reduction of CD4
staining in the target cell at the site of contact may be observed.
Similar results were obtained for monosynapses and polysynapses
formed between donor Dlg1+ or Dlg1- cells and primary CD4+
target T cells (Figure 2C). As indicated by the white arrows, Gag
and CD4 colocalized at the VS (Figure 2C top panel). After one
hour of co-culture, Gag puncta were visible on the target primary
CD4+ cells both on monosynapses and on polysynapses with
either Dlg1+ or Dlg1- cells. The quantification of cellular contacts,
monosynapses and polysynapses of three independent experiments
revealed that Dlg1- T cells were not impaired in HIV-1-induced
VS formation (Figure 2C bottom panel).
Together, these results show that in HIV-1-infected T cells
the absence of the scaffold protein Dlg1 does not affect Gag
localization to VS, cell-to-cell contact or VS formation in both
monosynapses and polysynapses.
HIV-1 cell-to-cell transmission in Dlg1-depleted T cells
We further studied whether Dlg1 could affect HIV-1 cell-to-cell
transmission. It has been largely documented that due to faster
transmission kinetics of cell-to-cell spread than cell-free virus
transmission, 24 h of co-culture is the time frame in which spread
of HIV-1 occurs by direct cell-to-cell transmission rather than by
free virus transmission [1,2,39,40]. Here, an equal number of
infected cells and target cells was mixed and co-cultured for up to
17 h. Virus transfer from infected Dlg1+ and Dlg1- Jurkat T cells
to target Jurkat or primary CD4+ T cells was quantified by
measuring intracellular Gag in target cells by flow cytometry at
different times. Gag transfer from Jurkat donor to Jurkat target T
cells was detected within 4 h of co-culture, increasing approxi-
mately fivefold by 17 h. At 17 h of co-culture no significant
difference was observed in the number of infected Jurkat T cell
targets, whether the donor cells were Dlg1+ or Dlg1- Jurkat T cells
(Figure 3A). Similar assays were performed with HIV-1-infected
Jurkat donor T cells and Dlg1+ or Dlg1- Jurkat targets T cells and
no difference was found in the number of infected Jurkat T cell
targets, whether the target cells were Dlg1+ or Dlg1- Jurkat T cells
(data not shown).
Co-culture assays were also performed with cell trace violet-
labeled primary CD4+ T cells as targets and no difference was
found in the number of primary CD4+ target T cells infected
whether the donor cells were Dlg1+ or Dlg1- Jurkat T cells
(Figure 3B).
To determine the level of viral transfer that results in effective
viral transmission, Jurkat-LTR-luciferase cells (1G5 cells) were
used as target cells. This cell line allows the quantification of
effective viral transmission by measuring the luciferase activity.
Similar luciferase activity was observed in 1G5 cells after co-
culture whether the donor infected cells were Dlg1+ or Dlg1-
Jurkat T cells (Figure 3C).
To evaluate the contribution of cell-free virus transmission
during the co-culture, supernatants of the different co-cultures
were further incubated under the same experimental conditions
for an additional 24 h period with target cells either primary
CD4+, Jurkat or 1G5 cells. No infection of target cells was
detected (not shown), confirming that our experimental conditions
allowed us to study cell-to-cell virus transmission. The results of
the different co-culture assays show that Dlg1 does not affect HIV-
1 cell-to-cell transfer or effective virus transmission in T cell lines
or primary T cells. Taken together, our data indicate that the
replication enhancement observed in Dlg1- T cells (Figure 1C) is
not the result of Dlg1 effects in cell-to-cell contact, VS formation
or cell-to-cell spread of HIV-1.
Levels of HIV-1 Gag and Env proteins in Dlg1-depleted T
cells and in particles produced
The role of Dlg1 in cell-free virus transmission was further
examined by studying the late steps of the viral life cycle such as
virus yield and infectivity. HIV-1 yield during infection was
followed in Dlg1+ and Dlg1- Jurkat T cells infected with HIV-1 by
measuring by ELISA at different times the levels of p24 released in
the supernatants. Virus yield was increased at 5 and 7 dpi in the
Dlg1- Jurkat T cell culture compared to the Dlg1+ Jurkat T cell
culture (Figure 4A).
The infectivity of viral particles produced by Dlg1- and Dlg1+ T
cells was determined by their capacity to infect HeLa CD4+
indicator target cells. HIV-1 particles produced by Dlg1- cells 7
dpi showed a fourfold increase in infectivity compared to the
particles produced by the Dlg1+ cells (Figure 4B). This study
performed using stably Dlg1-depleted T cells infected with HIV-1
confirmed previous studies performed with adherent 293T cells
depleted of Dlg1 by siRNA and transfected with a proviral HIV-1
plasmid [18]. Collectively, the results of virus yield and infectivity
indicate that the enhanced HIV-1 replication observed in Dlg1- T
cells (Figure 1C) results from a combination of increased yield and
Dlg1 modulation of cell-free virus transmission.
To determine if the increased infectivity of viral particles
produced by Dlg1- cells results from a higher incorporation of Env
into viral particles, western blot analyses were performed on
protein extracts of HIV-1-infected Dlg1+ and Dlg1- cells and of
the viruses they produced. Figure 4C summarizes the results of
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PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e30130Figure 2. Dlg1 depletion affects IS but not VS formation in T cells. A. MTOC polarization toward the nascent IS in Dlg1+ and Dlg1-
Jurkat T cells. Left panel: IS conjugates were formed between Jurkat and APC (Raji B) cells. Phosphotyrosine accumulation at the interface between
two contacting cells served as marker of a productive IS contact that led to TCR activation and to activation of the downstream signaling cascade.
Centrin was visualized simultaneously to localize the MTOC. A polarized MTOC in a Dlg1+ T cell and an unpolarized MTOC in a Dlg1- T cell are seen.
The nuclei of Jurkat T cells are shown in blue, the MTOCs are shown in red and indicated by a white arrow. The phosphotyrosine (PTYR) is shown in
magenta. The results shown were obtained with the pHIV-H1shRNADlg1 and pHIV-H1shRNACtl vectors expressing the GFP. Similar results were
obtained with cells transduced with the lentivirus vectors pHIV-H1shRNADlg1 and Mission shRNADlg1. Right panel: Quantification of MTOC
polarization observed in Dlg1+ (n=131) and Dlg1- (n=151) T cells in four independent experiments. P=0.029. B. Cellular localization of Gag in
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Dlg1- cells compared to level in Dlg1+ cells was two to sixfold
higher (gp160+gp120 normalized with respect to Gag). Whereas
the amount of virus-associated Env in the viruses produced by
Dlg1- T cells compared to that in the virus produced by Dlg1+
cells was halffold lower to threefold higher (gp120 normalized with
respect to Gag). Infectivity of viruses produced by Dlg1- cells was
increased from two to sixfold while the extinction of Dlg1 in these
cells was from 50 to 80%. The results of experiment 4 (Figure 4C
and D) show that Dlg1 depletion did not affect Gag production
in Dlg1- T cells (Pr55Gag and p24; Figure 4D left panel) and
that while a sixfold increase in intracellular Env was observed in
Dlg1- T cells, the viruses produced by these cells showed 50%
reduction of virus-associated Env and a fivefold increase in
infectivity as compared to viruses produced by Dlg1+ T cells. In
summary, Dlg1 depletion in T cells does not affect Gag synthesis
but enhances cell-associated Env and virus infectivity. On the
other hand, the changes observed on virus-associated Env did not
always correlate with enhanced infectivity. To determine if the
Env level at the plasma membrane is affected by Dlg1, the cell-
surface level of HIV-1 Env was quantified by flow cytometry. No
difference in Env cell-surface levels in HIV-1-infected Dlg1+
and Dlg1- Jurkat T cells was observed (Figure 4E). Consequently,
viral particles budding at the plasma membrane of Dlg1+ and
the presence and absence of Dlg1. Dlg1+ and Dlg1- Jurkat T cells were immunostained for Gag and for Dlg1. White arrows indicate Gag
accumulation at the VS. The images shown are representative of three independent experiments. C. VS formation in Dlg1+ and Dlg1- Jurkat T
cells. Upper panel: HIV-1-infected Dlg1+ and Dlg1- Jurkat T cells were mixed with an equal number of non-infected primary CD4+ target cells and
were allowed to establish contacts on poly-L-lysine-coated coverslips for 1 h at 37uC. The cells were fixed, permeabilized, immunostained for Gag and
CD4 and analyzed by confocal microscopy. Monosynapses were defined as contacts between a single effector and a single target cell presenting co-
localization (in white) of Gag on the infected cell and of CD4 on the CD4+ target cell at sites of contact. Polysynapses were defined as contacts
between a single effector cell and multiple target cells. Lower panel: Quantification of cellular contacts, monosynapses and polysynapses between
HIV-1-infected Dlg1+ or Dlg1- Jurkat T cells and CD4+ target cells. A total of 1603 Dlg1+ control T cells and 1616 Dlg1- T cells were counted. The
data are the means of 3 independent experiments. P=0.7 for contacts. P=1.0 for monosynapses. P=1.0 for polysynapses. Error bars represent SEM.
ns = no statistically significant difference. *, P,0.05. Scale bar = 5 mm.
doi:10.1371/journal.pone.0030130.g002
Figure 3. HIV-1 cell-to-cell transmission is not affected in Dlg1-depleted T cells. A. Co-culture of HIV-1-infected Dlg1+ and Dlg1-
Jurkat and target Jurkat Dlg+ T cells. Dlg1+ and Dlg1- Jurkat T cells infected with HIV-1 NL4.3 were co-cultured with target Jurkat cells. When a
minimum level of 20% infection was reached for both Dlg1+ and Dlg1- cells, equal numbers of infected and target cells were mixed and co-cultured
for up to 17 h. At different times after infection the cells were analyzed by flow cytometry to determine the percentage of infected target cells.
Results are mean relative values of six independent experiments performed in duplicate. For each experiment the values were normalized taking as
100% the value obtained for one of the duplicates of Dlg1+ cells at 17h. P=0.26 at 17 h. Assays were performed with cells transduced with the two
lentivirus vectors (pHIV-H1shRNA and Mission shRNA) and similar results were obtained. The results obtained with the GFP-encoding vectors are
presented. B. Co-culture of HIV-1-infected Dlg1+ and Dlg1- Jurkat and target CD4+ primary T cells. Dlg1+ and Dlg1- Jurkat T cells infected
with HIV-1 NL4.3 were co-cultured with primary CD4+ T cells previously labeled with cell trace violet. Infected and target cells were co-cultured at a
1:1 ratio for up to 17 h and analyzed by flow cytometry. The data are average values of three independent experiments performed in duplicate.
P=0.31. C. Co-culture of HIV-1-infected Dlg1+ and Dlg1- Jurkat and target Jurkat-LTR-luciferase T cells. Dlg1+ and Dlg1- Jurkat T cells
infected with HIV-1 NL4.3 were co-cultured with Jurkat-LTR-luciferase cells (1G5 cells). Infected and target cells were co-cultured at a 1:1 ratio for up
to 24 h and analyzed for luciferase activity. The data are average relative values of three independent experiments performed in duplicate. The values
were normalized taking the values obtained for 1G5 cells at 24 h as background for each experiment. P=0.7. Error bars represent SEM. ns = no
statistically significant difference.
doi:10.1371/journal.pone.0030130.g003
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PLoS ONE | www.plosone.org 8 January 2012 | Volume 7 | Issue 1 | e30130Figure 4. The levels of HIV-1 Env incorporated into viral particles produced by Dlg1-depleted T cells do not correlate with
increased infectivity. A. HIV-1 yield of Dlg1+ and Dlg1- T cells. Supernatants were collected during the course of infection, filtered and the
p24 content was measured by ELISA. The values were normalized for protein content of extracts of cultured cells. The data are the mean values of
three independent experiments each carried out in duplicate. For each experiment the values were normalized taking as 100% the value obtained for
one of the duplicates of Dlg1+ cells at 7 dpi. P=0.007 for 5 dpi. P=0.02 for 7 dpi. B. Infectivity of HIV-1 particles produced by Dlg1+ and
Dlg1- T cells. Viral supernatants of Dlg1+ and Dlg1- Jurkat T cells infected with HIV-1 NL4.3 were collected 7 dpi, filtered and used to infect indicator
HeLa P4.2 reporter cells. Equal amounts of virus determined by p24 quantification were used. ß-galactosidase production was assessed by a
colorimetric assay based on cleavage of CPRG. The data are means of four independent experiments carried out in triplicate. P=0.0004. C. Summary
of quantification of cell-associated Env in Dlg1+ and Dlg1- cells and of virus-associated Env in progeny viruses. The cell-associated
Env levels were estimated from the intensity of the signals on western blots and calculated as gp160+gp120/Gag in cell lysates. Equal amounts of
total protein in lysates of Dlg1+ and Dlg1- HIV-1-infected cells recovered 5 dpi were analyzed using antibodies against HIV-1 Gag and Env. The virus-
associated Env levels (gp120) were estimated from the intensity of the signals on the western blots; equal amounts of p24 of purified viruses from
supernatants of Dlg1+ and Dlg1- HIV-1-infected cells were analyzed using antibodies against HIV-1 Gag and Env. The infectivity of these viruses was
determined as described in B. The data are from four independent experiments. D. Western blot analysis of protein extracts of Dlg1+ and
Dlg1- cells and of purified viruses produced. Results of experiment 4 are shown. Left panel: equal amounts of total protein in lysates of Dlg1+
and Dlg1- HIV-1-infected cells recovered 5 dpi were analyzed using antibodies against HIV-1 Gag and Env, against Dlg1 and against GAPDH. Right
panel: equal amounts of p24 of purified viruses from supernatants of Dlg1+ and Dlg1- HIV-1-infected cells were analyzed using antibodies against
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levels of Env. Collectively, the results indicate that the increase in
infectivity of particles produced by Dlg1- T cells does not correlate
with an increase in levels of Env incorporated in these particles
and that therefore virus-associated Env level alone is not
responsible for the observed increase in infectivity.
Subcellular distribution of HIV-1 particles in
Dlg1-depleted T cells
In a previous study we observed by confocal microscopy that
Gag and Env were relocalized to apparently internal compartments
in unconjugated Dlg1- T cells transfected with LAI.2 HIV-1-
proviral clones [18]. To extend those studies with stably depleted
Jurkat T cells infected with HIV-1, we examined by electron
microscopy the subcellular distribution of viral particles in uncon-
jugated cells. Cell cultures with a minimum of 60% infected cells
were used for these experiments. Viral particles were seen in 6% of
the cells by electron microscopy (i.e. in 10% of the infected cells).
Viral particles budded exclusively from the plasma membrane in
all virus-producing Dlg1+ Jurkat T cells as well as in 96% of
Dlg1- Jurkat T cells (Figure 5A). Viral particles were seen in in-
ternal compartments in the remaining 4% of the virus-producing
HIV-1 Gag and Env. E. Cell-surface level of HIV-1 Env on Dlg1+ and Dlg1- HIV-1-infected T cells. The cell-surface level of HIV-1 Env was
determined by flow cytometry analysis using the anti-Env 5F7 antibodies. HIV-1-infected Dlg1+ and Dlg1- Jurkat T cells were analyzed 5 dpi. Two
independent experiments were carried out in duplicate. Error bars represent SEM. ns = no statistically significant difference. *, P,0.05. **, P,0.01.
***, P,0.001.
doi:10.1371/journal.pone.0030130.g004
Figure 5. Budding of HIV-1 particles in Dlg1- Jurkat T cells occurs at the plasma membrane and in internal compartments. A.
Budding of HIV-1 particles in Dlg1- Jurkat T cells from the plasma membrane. Dlg1+ and Dlg1- Jurkat T cells infected with HIV-1 were
examined 6 dpi, when infection was about 60%, by electron microscopy in cells not forced to form conjugates. A total of 320 Dlg1+ Jurkat T cells (out
of 5300) showing viral particles and of 392 Dlg1- Jurkat T cells (out of 6500) showing viral particles were counted. Budding from plasma membrane
was identical in Dlg1+ and Dlg1- cells; the image presented is of a Dlg1- Jurkat T cell. Two independent experiments were performed with both NL4.3
and LAI.2 HIV-1. B. Budding of HIV-1 particles in Dlg1- Jurkat T cells from internal compartments. Cells were treated as above. Budding
and mature particles are seen in an internal compartment in a Dlg1- Jurkat cell. C and D. HIV-1 particles in internal compartments of Dlg1-
Jurkat T cells. Mature particles are seen in the enlargement in D. E and F. HIV-1 particles in compartments near the plasma membrane of
Dlg1- Jurkat T cells. Mature particles are seen in the enlargement in F. Same magnification was used in C and E and in D and F. P=0.02 for NL4.3.
P=0.01 for LAI.2 infected cells. Scale is 0.5 mm for A, D and F, 2 mm for C and E and 100 nm for B.
doi:10.1371/journal.pone.0030130.g005
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course of budding were observed in some of these compartments
(Figure 5B). Two types of compartments were observed, large ones
close to the nucleus (Figure 5C and D) and small ones near the
plasma membrane (Figure 5E and F). The small ones may be
invaginations of the plasma membrane, whereas the large ones are
most likely internal compartments based on their size and
localization inside the cell. Finally, 4% of virus producing cells of
both Dlg1+ and Dlg1- cells showed small shallow invaginations
(data not shown). No large deep invaginations were observed in any
of the two types of cells. Similar results were obtained for Jurkat T
cells infected with pNL4.3 and LAI.2 HIV-1. Statistical analyses
using the chi2 test indicate that the presence of virus-containing
internal compartments is significantly due to the absence of Dlg1 in
the infected cells (P=0.02 for pNL4.3 and P=0.01 for LAI.2
infected cells). These electron microscopy studies show for the first
time virus-containing internal compartments in acutely HIV-
1-infected Dlg1- Jurkat T cells. They confirm our previous
observations with confocal microscopy [18] and open the way for
future characterization of the nature of the internal compartments
aswellasthe elucidationoftherole ofthesecompartmentsinHIV-1
trafficking in T cells.
Role of Dlg1 in cell-free virus transmission
To investigate at which step Dlg1 affects infectivity of cell-free
virus, total viral DNA was determined by quantitative PCR of
HIV-1 DNA, 6 h after infection of Jurkat cells with NL4.3 HIV-1
produced by Dlg1+ or Dlg1- cells. A fourfold accumulation of total
viral DNA was observed in Jurkat cells infected with virus
produced by Dlg1- cells compared to Jurkat cells infected with
virus produced by Dlg1+ cells (Figure 6A). Similar results were
obtained when infections were performed with LAI.2 HIV-1.
Thus the effect of Dlg1 on virus infectivity takes place at early steps
of the virus life cycle, either entry or reverse transcription.
Cholesterol plays a key role in the HIV-1 life cycle; it was shown
that viral infectivity correlates with viral cholesterol content and
that virus-cell fusion capacity was directly linked with viral
cholesterol [41]. Since Dlg1 coordinates the aggregation of lipids
rafts during IS formation [24], the cholesterol content of viral
particles produced by Dlg1 + and Dlg1- cells was examined. The
Figure 6. HIV-1 particles produced by Dlg1-depleted cells accumulated higher total HIV-1 DNA amounts during the first hours of
infection and have increased cholesterol content. A. Quantification of total viral DNA. Total viral DNA was quantified by quantitative PCR
in Jurkat T cells 6 h after infection with NL4.3 or LAI.2 HIV-1 particles produced by Dlg1+ and Dlg1- cells. The results are expressed as mean NRQ
(normalized RQ described in materials and methods). Values are from one representative experiment performed in triplicate for infection and in
triplicate for qPCR. P=0.001. B. Viral cholesterol content of HIV-1 particles produced by 293T cells. Dlg1- 293T cells were obtained by siRNA
transfection. The cholesterol content of LAI.2 HIV-1 produced by Dlg1+ or Dlg1- 293T cells was determined. The data are the means of three
independent experiments performed in duplicate. For each experiment the values were normalized to the value obtained with one of the duplicates
of viruses from Dlg1+ cells taken as 100%. P=0.0026. C. Viral cholesterol content of HIV-1 particles produced by Jurkat T cells. Cholesterol
content of LAI.2 HIV-1 produced by Dlg1+ or Dlg1- Jurkat T cells was determined. The data are the means of one experiment performed in duplicate.
The values were normalized to the value obtained for one of the duplicates of viruses from Dlg1+ cells taken as 100%. Error bars represent SEM.
**, P,0.01.
doi:10.1371/journal.pone.0030130.g006
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293T cells depleted of Dlg1 was increased 1.7 fold compared to
the cholesterol content of particles produced by control Dlg1+ cells
(Figure 6B). This increase was in excellent correlation with the
enhancement of infectivity of 1.8 fold observed for these particles.
Similarly, the cholesterol content of the viruses produced by LAI.2
HIV-1 infected Dlg1- Jurkat T cells showing a 1.5 fold increased
infectivity was increased 1.5 fold compared to the cholesterol
content of the viruses produced by Dlg1+ cells (Figure 6C). These
results show a robust correlation between the increase in
cholesterol levels of HIV-1 particles produced by Dlg1- cells and
their increased infectivity.
In conclusion, the increased accumulation of total viral DNA a
few hours after infection with particles produced by Dlg1- cells,
together with the increased cholesterol content of these particles
and the fact that viral cholesterol content has been reported to
determine fusion capacity of HIV-1 [41], are good indications that
the effect of Dlg1 on HIV-1 infectivity is probably at the step of
virus-cell fusion.
Discussion
Dlg1 organizes signaling complexes at cellular contacts and
particularly in T cells at the IS, where it is involved in the assembly
and localization of TCR proximal signaling molecules and in the
link between the TCR signaling machinery and regulators of the
cytoskeleton [20,23,24]. The possible implication of Dlg1 in the
VS had not been studied previously. We show here by IF and
confocal microscopy studies that Dlg1 is involved in IS formation,
but its depletion in T cells does not prevent conjugate formation or
HIV-1-induced formation of both monosynapses and polysy-
napses. In addition, co-culture studies show that Dlg1 does not
affect HIV-1 cell-to-cell transfer or effective virus transmission in
T cells. Taken together, our results show that despite its key role in
IS formation and T cell signaling, Dlg1 is dispensable for HIV-1
induced VS formation in T cells. The different role of Dlg1 in the
IS and the VS, is consistent with the recent conclusion that while
HIV-1 uses common structural components of the IS to form the
VS, the latter has different morphological features, dynamics,
intracellular signaling events and cytoskeleton reorganization [42].
Dlg1 is the only protein of the MAGUK family that has been
identified and extensively studied in T cells [34] and the shRNAs
used here specifically target Dlg1 but not the other proteins of the
family. Therefore, it cannot be excluded that other proteins of this
family could be present in T cells and compensate for the lack of
Dlg1. We provide evidence that in stably depleted Dlg1 T cells the
infectivity of the viral particles produced is enhanced. Since
specific knockdown of Dlg1 is sufficient to affect HIV-1 particle
infectivity, this indicates that in T cells Dlg1 is the main protein of
the Dlg family involved in modulation of HIV-1 infectivity.
Our results show that HIV-1 infection of Dlg1- Jurkat T cells
results in progeny viruses with enhanced infectivity and that in
these cells the early steps of the HIV-1 life cycle are not affected.
The absence of correlation between the level of virus-associated
Env and the increase in virus infectivity observed in the present
study is in contrast with our previous report [18]. The reason for
this discrepancy is unknown; it may be attributable to differences
between stable and transient depletion, transfection and infection
or to cell type-specific differences. In our previous studies,
biochemical analyses were performed in readily transfected
293T cells, rather than in T cells that are targets for productive
HIV-1 infection as used in the present study. The absence of
correlation between the level of virus-associated Env and the
increase in virus infectivity is in agreement with a report where
HIV-1 infectivity was not modified by a threefold increase in virus-
associated Env content [43]. In addition, it was observed for Simian
immunodeficiency virus (SIV) that a fiftyfold increase in virus-
associated Env content only increased infectivity to two to
threefold [44]. It was proposed that the effects of virus-associated
Env content on infectivity are likely to depend on the SIV strain,
the cell line and the co-receptor used [44].
Here we present viral-containing internal compartments in
acutely HIV-1-infected Dlg1- Jurkat T cells. These exciting results
open the way for the determination of the nature of these internal
compartments as well as for the elucidation of their role in HIV-1
trafficking in T cells. Are these compartments late endosomes/
multivesicular bodies as described in macrophages [45,46,47] and
in chronically infected T cells [48] or are they invaginations of the
plasma membrane as proposed for macrophages [49,50]? What is
the kinetics of formation of these compartments? Viral particles
budding into these compartments were observed, indicating that at
least some of these compartments are sites of particle assembly.
Are these sites where more efficient assembly of virus particles
occurs? It will be interesting to compare the infectivity, protein
composition and cholesterol content of viral particles from the
internal compartments to those from the supernatant of cell
cultures at different times during infection, in order to elucidate
the role of the internal compartments in the assembly of infectious
HIV-1 virions.
The lipids of enveloped viruses play a key role in viral
morphogenesis and infectivity and many viruses modify host
cholesterol metabolism to optimize their replication. Increased
infectivity of viral particles produced by Dlg1- T cells may result
from different compositions of lipids of the host membrane
microdomains from which virus budding occurs. Dlg1 coordinates
synaptic lipid raft clustering during IS formation [24] and as a
scaffold protein, it may alter the composition of lipids or proteins
of the membranes where HIV-1 buds, acting on their incorpora-
tion into viral particles. HIV-1 buds from cholesterol rich
membrane microdomains [51]. The overall lipid composition of
HIV-1 resembles detergent-resistant membrane microdomains
[52]. In addition, HIV-1 Nef enhanced the cholesterol content of
HIV-1 progeny virions and increased their infectivity, while
inhibiting the activity of the major cellular cholesterol transporter,
the ATP binding cassette transporter A1 (ABCA1) [53].
Interestingly, it was reported that Dlg1 interacts with ABCA1
[54]. Reduced HIV-1 fusion activity was directly linked to reduced
viral cholesterol content [41]. The Membrane Proximal External
Region (MPER) preceding the transmembrane domain of the
HIV-1 gp41 subunit was shown to be required for fusion activity
by destabilizing the viral envelope and MPER fusogenic activity is
enhanced by cholesterol [55,56]. In this context, our results of
increased infectivity and increased cholesterol content of HIV-1
particles produced by Dlg1- cells, together with increased
accumulation of total viral DNA a few hours after infection of T
cells with particles produced by Dlg1- cells, indicate that the effect
of Dlg1 on HIV-1 infectivity is probably at the step of virus-cell
fusion. To test this hypothesis, numerous experiments were
performed with pseudotyped viruses as well as using the fluo-
rescence resonance energy transfer-based HIV-1 virion fusion
assay [57]. In all experiments using these systems to produce
viruses in 293T cells depleted of Dlg1, the virions produced were
less infectious than the control ones produced by Dlg1+ cells (data
not shown). This phenotype is the opposite of the one obtained
with wild type HIV-1 and underlines the important role of Dlg1 in
the production of infectious particles.
Alternatively, increased infectivity may result from the activity
of host factor(s) differentially incorporated into viral particles in the
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particles [18] and it has not been reported in proteomic studies of
HIV-1 [58,59],[60]. The HIV-1 proteome analyses have identified
a vast number of host proteins incorporated into virions (http://
web.ncifcrf.gov/research/avp/). In this list are included the cell
surface receptor cluster of differentiation 2 (CD2) and Lck, two cell
proteins with which Dlg1 interacts. CD2 was found differentially
incorporated in virus from sooty mangabeys but not from rhesus
macaques infected by SIV [61]. CD2 will be tested in future
studies for its possible differential incorporation into HIV-1
particles produced by Dlg1+ and Dlg1- T cells that could affect
HIV-1 binding to target cells. Proteomic and lipidomic analyses of
highly purified HIV-1 particles produced by Dlg1+ and Dlg1- T
cells are needed to determine the nature of the factor(s) increasing
infectivity of particles produced in the absence of Dlg1.
Increased infectivity of the virus produced by Dlg1- cells does
not result in increased cell-to-cell HIV-1 transmission in these
cells, indicating that cell-to-cell HIV-1 transmission in co-culture
can overcome barriers that efficiently limit cell-free transmission.
Compared to viruses produced by Dlg1- cells, viruses produced by
cells expressing endogenous Dlg1 may have either reduced
stability, reduced affinity for target cells or may be less efficient
in fusion and replication. We proposed that by controlling the
cholesterol content of HIV-1 particles, Dlg1 may regulate the
fusion capacity of the particles, and that when these viruses are
shed at high concentrations into the cleft of the VS directly next to
the target cell, multiple viruses may enter the target cell,
overcoming the reduced fusion capacity of individual particles.
That multiple copies of HIV-1 can be co-transmitted across a
single VS and infect a target cell was recently demonstrated [62].
In conclusion, we demonstrate for the first time that despite the
key role of the scaffolding protein Dlg1 in the IS formation and T
cell signaling, Dlg1 does not affect the VS formation or cell-to-cell
spread of HIV-1. We further demonstrate that Dlg1 plays a role in
HIV-1 cell-free virus transmission and postulate that by modifying
viral cholesterol content Dlg1 affects the step of virus-cell fusion.
Our studies will have important implications for understanding
how Jurkat and CD4+ primary T cells can rescue the deficiencies
of cell-free virus by cell-to-cell transmission. Further insights into
the role of Dlg1 on lipids or other host factors incorporation into
HIV-1 may provide new ideas on the relationship between
structure and function of infectious viral particles.
Acknowledgments
The authors thank Dr. Eric Freed for materials and for critical reading of
the manuscript, Dr. Morgan Bomsel, Dr. Agnes Fouet and Dr. Harry
Taylor for helpful discussions, Dr. Anne-Lise Haenni for critical reading of
the manuscript, Dr. Stephane Emiliani, members of his group and
members of the Genomic and transcriptomic facility of the Cochin Institute
for help with the quantitative PCR, Dr. Cloe ´ Paul-Victor for help with the
statistical analyses, and members of the Cellular Imaging and of the Flow
Cytrometry facilities of the Cochin Institute for their help. We thank the
AIDS Research and Reference Reagent Program, Division of AIDS,
NIAID, NIH, for the following reagents that were obtained through the
program: 1G5 cells from Dr. Estuardo Aguilar-Cordova and Dr. John
Belmont; HIV-1LAI (BRU) V3 monoclonal Antibody (5F7) from Dr.
Albrecht von Brunn; HIV-1 SFE p24 Antiserum and CXCR4 Monoclonal
Antibody (12G5) from Dr. James Hoxie and HIV-1 anti-p24 mAb (#24-2).
Author Contributions
Conceived and designed the experiments: PN CR CP BCR. Performed the
experiments: PN MC CG AS JMM BCR. Analyzed the data: PN MC CG
CR CP BCR. Contributed reagents/materials/analysis tools: CR. Wrote
the paper: PN CP BCR.
References
1. Chen P, Hubner W, Spinelli MA, Chen BK (2007) Predominant mode of
human immunodeficiency virus transfer between T cells is mediated by
sustained Env-dependent neutralization-resistant virological synapses. J Virol
81: 12582–12595.
2. Sourisseau M, Sol-Foulon N, Porrot F, Blanchet F, Schwartz O (2007) Inefficient
human immunodeficiency virus replication in mobile lymphocytes. J Virol 81:
1000–1012.
3. Blanco J, Bosch B, Fernandez-Figueras MT, Barretina J, Clotet B, et al. (2004)
High level of coreceptor-independent HIV transfer induced by contacts between
primary CD4 T cells. J Biol Chem 279: 51305–51314.
4. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, et al. (1993)
Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol
67: 2182–2190.
5. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, et al. (2008)
Membrane nanotubes physically connect T cells over long distances presenting a
novel route for HIV-1 transmission. Nat Cell Biol 10: 211–219.
6. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, et al.
(2007) Retroviruses can establish filopodial bridges for efficient cell-to-cell
transmission. Nat Cell Biol 9: 310–315.
7. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ (2004) HIV-1 cell to cell
transfer across an Env-induced, actin-dependent synapse. J Exp Med 199:
283–293.
8. Jolly C, Sattentau QJ (2004) Retroviral spread by induction of virological
synapses. Traffic 5: 643–650.
9. Alfsen A, Yu H, Magerus-Chatinet A, Schmitt A, Bomsel M (2005) HIV-1-
infected blood mononuclear cells form an integrin- and agrin-dependent viral
synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer.
Mol Biol Cell 16: 4267–4279.
10. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, et al. (2003)
Spread of HTLV-I between lymphocytes by virus-induced polarization of the
cytoskeleton. Science 299: 1713–1716.
11. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, et al. (2003)
Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science
300: 1295–1297.
12. Mothes W, Sherer NM, Jin J, Zhong P (2010) Virus cell-to-cell transmission.
J Virol 84: 8360–8368.
13. Sattentau Q (2008) Avoiding the void: cell-to-cell spread of human viruses. Nat
Rev Microbiol 6: 815–826.
14. Thoulouze MI, Sol-Foulon N, Blanchet F, Dautry-Varsat A, Schwartz O, et al.
(2006) Human immunodeficiency virus type-1 infection impairs the formation of
the immunological synapse. Immunity 24: 547–561.
15. Freed EO, Mouland AJ (2006) The cell biology of HIV-1 and other retroviruses.
Retrovirology 3: 77.
16. Fujii K, Hurley JH, Freed EO (2007) Beyond Tsg101: the role of Alix in
‘ESCRTing’ HIV-1. Nat Rev Microbiol 5: 912–916.
17. Fujii K, Munshi UM, Ablan SD, Demirov DG, Soheilian F, et al. (2009)
Functional role of Alix in HIV-1 replication. Virology 391: 284–292.
18. Perugi F, Muriaux D, Ramirez BC, Chabani S, Decroly E, et al. (2009) Human
Discs Large is a new negative regulator of human immunodeficiency virus-1
infectivity. Mol Biol Cell 20: 498–508.
19. Krummel MF, Macara I (2006) Maintenance and modulation of T cell polarity.
Nat Immunol 7: 1143–1149.
20. Ludford-Menting MJ, Oliaro J, Sacirbegovic F, Cheah ET, Pedersen N, et al.
(2005) A network of PDZ-containing proteins regulates T cell polarity and
morphology during migration and immunological synapse formation. Immunity
22: 737–748.
21. Xavier R, Rabizadeh S, Ishiguro K, Andre N, Ortiz JB, et al. (2004) Discs large
(Dlg1) complexes in lymphocyte activation. J Cell Biol 166: 173–178.
22. Hanada T, Lin L, Chandy KG, Oh SS, Chishti AH (1997) Human homologue
of the Drosophila discs large tumor suppressor binds to p56lck tyrosine kinase
and Shaker type Kv1.3 potassium channel in T lymphocytes. J Biol Chem 272:
26899–26904.
23. Shaw AS, Filbert EL (2009) Scaffold proteins and immune-cell signalling. Nat
Rev Immunol 9: 47–56.
24. Round JL, Tomassian T, Zhang M, Patel V, Schoenberger SP, et al. (2005)
Dlgh1 coordinates actin polymerization, synaptic T cell receptor and lipid raft
aggregation, and effector function in T cells. J Exp Med 201: 419–430.
25. Lasserre R, Charrin S, Cuche C, Danckaert A, Thoulouze MI, et al. (2010)
Ezrin tunes T-cell activation by controlling Dlg1 and microtubule positioning at
the immunological synapse. EMBO J 29: 2301–2314.
26. Ilani T, Khanna C, Zhou M, Veenstra TD, Bretscher A (2007) Immune synapse
formation requires ZAP-70 recruitment by ezrin and CD43 removal by moesin.
J Cell Biol 179: 733–746.
27. Blanchard N, Di Bartolo V, Hivroz C (2002) In the immune synapse, ZAP-70
controls T cell polarization and recruitment of signaling proteins but not
formation of the synaptic pattern. Immunity 17: 389–399.
Dlg1 in VS Formation and HIV-1 Transmission
PLoS ONE | www.plosone.org 13 January 2012 | Volume 7 | Issue 1 | e3013028. Sol-Foulon N, Sourisseau M, Porrot F, Thoulouze MI, Trouillet C, et al. (2007)
ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse
formation. EMBO J 26: 516–526.
29. von Brunn A, Brand M, Reichhuber C, Morys-Wortmann C, Deinhardt F, et al.
(1993) Principal neutralizing domain of HIV-1 is highly immunogenic when
expressed on the surface of hepatitis B core particles. Vaccine 11: 817–824.
30. Endres MJ, Clapham PR, Marsh M, Ahuja M, Turner JD, et al. (1996) CD4-
independent infection by HIV-2 is mediated by fusin/CXCR4. Cell 87:
745–756.
31. Kiernan RE, Ono A, Englund G, Freed EO (1998) Role of matrix in an early
postentry step in the human immunodeficiency virus type 1 life cycle. J Virol 72:
4116–4126.
32. Murakami T, Freed EO (2000) The long cytoplasmic tail of gp41 is required in a
cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into
virions. Proc Natl Acad Sci U S A 97: 343–348.
33. Blot V, Delamarre L, Perugi F, Pham D, Benichou S, et al. (2004) Human Dlg
protein binds to the envelope glycoproteins of human T-cell leukemia virus type
1 and regulates envelope mediated cell-cell fusion in T lymphocytes. J Cell Sci
117: 3983–3993.
34. Funke L, Dakoji S, Bredt DS (2005) Membrane-associated guanylate kinases
regulate adhesion and plasticity at cell junctions. Annu Rev Biochem 74:
219–245.
35. Brussel A, Sonigo P (2004) Evidence for gene expression by unintegrated human
immunodeficiency virus type 1 DNA species. J Virol 78: 11263–11271.
36. Pfaffl MW (2001) A new mathematical model for relative quantification in real-
time RT-PCR. Nucleic Acids Res 29: e45.
37. Martin-Cofreces NB, Robles-Valero J, Cabrero JR, Mittelbrunn M, Gordon-
Alonso M, et al. (2008) MTOC translocation modulates IS formation and
controls sustained T cell signaling. J Cell Biol 182: 951–962.
38. Stinchcombe JC, Majorovits E, Bossi G, Fuller S, Griffiths GM (2006)
Centrosome polarization delivers secretory granules to the immunological
synapse. Nature 443: 462–465.
39. Jolly C, Booth NJ, Neil SJ (2010) Cell-cell spread of human immunodeficiency
virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. J Virol
84: 12185–12199.
40. Jolly C, Mitar I, Sattentau QJ (2007) Requirement for an intact T-cell actin and
tubulin cytoskeleton for efficient assembly and spread of human immunodefi-
ciency virus type 1. J Virol 81: 5547–5560.
41. Morrow MP, Grant A, Mujawar Z, Dubrovsky L, Pushkarsky T, et al. (2010)
Stimulation of the liver X receptor pathway inhibits HIV-1 replication via
induction of ATP-binding cassette transporter A1. Mol Pharmacol 78: 215–225.
42. Vasiliver-Shamis G, Dustin ML, Hioe CE (2010) HIV-1 Virological Synapse is
not Simply a Copycat of the Immunological Synapse. Viruses 2: 1239–1260.
43. Lopez-Verges S, Camus G, Blot G, Beauvoir R, Benarous R, et al. (2006) Tail-
interacting protein TIP47 is a connector between Gag and Env and is required
for Env incorporation into HIV-1 virions. Proc Natl Acad Sci U S A 103:
14947–14952.
44. Yuste E, Reeves JD, Doms RW, Desrosiers RC (2004) Modulation of Env
content in virions of simian immunodeficiency virus: correlation with cell surface
expression and virion infectivity. J Virol 78: 6775–6785.
45. Nydegger S, Foti M, Derdowski A, Spearman P, Thali M (2003) HIV-1 egress is
gated through late endosomal membranes. Traffic 4: 902–910.
46. Ono A, Freed EO (2004) Cell-type-dependent targeting of human immunode-
ficiency virus type 1 assembly to the plasma membrane and the multivesicular
body. J Virol 78: 1552–1563.
47. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, et al.
(2003) Visualization of retroviral replication in living cells reveals budding into
multivesicular bodies. Traffic 4: 785–801.
48. Grigorov B, Arcanger F, Roingeard P, Darlix JL, Muriaux D (2006) Assembly of
infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J Mol Biol
359: 848–862.
49. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M (2007) In
macrophages, HIV-1 assembles into an intracellular plasma membrane domain
containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 177: 329–341.
50. Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, et al.
(2007) HIV-1 buds predominantly at the plasma membrane of primary human
macrophages. PLoS Pathog 3: e36.
51. Ono A, Freed EO (2001) Plasma membrane rafts play a critical role in HIV-1
assembly and release. Proc Natl Acad Sci U S A 98: 13925–13930.
52. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, et al. (2006) The
HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A
103: 2641–2646.
53. Mujawar Z, Rose H, Morrow MP, Pushkarsky T, Dubrovsky L, et al. (2006)
Human immunodeficiency virus impairs reverse cholesterol transport from
macrophages. PLoS Biol 4: e365.
54. Fitzgerald ML, Okuhira K, Short GF 3rd, Manning JJ, Bell SA, et al. (2004)
ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA
motif that is required for its cholesterol efflux and ApoA-I binding activities.
J Biol Chem 279: 48477–48485.
55. Saez-Cirion A, Nir S, Lorizate M, Agirre A, Cruz A, et al. (2002) Sphingomyelin
and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface
aggregation and membrane restructuring. J Biol Chem 277: 21776–21785.
56. Nieva JL, Apellaniz B, Huarte N, Lorizate M (2011) A new paradigm in
molecular recognition? Specific antibody binding to membrane-inserted HIV-1
epitopes. J Mol Recognit 24: 642–646.
57. Cavrois M, De Noronha C, Greene WC (2002) A sensitive and specific enzyme-
based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat
Biotechnol 20: 1151–1154.
58. Booth AM, Fang Y, Fallon JK, Yang JM, Hildreth JE, et al. (2006) Exosomes
and HIV Gag bud from endosome-like domains of the T cell plasma membrane.
J Cell Biol 172: 923–935.
59. Chertova E, Chertov O, Coren LV, Roser JD, Trubey CM, et al. (2006)
Proteomic and biochemical analysis of purified human immunodeficiency virus
type 1 produced from infected monocyte-derived macrophages. J Virol 80:
9039–9052.
60. Ott DE (2008) Cellular proteins detected in HIV-1. Rev Med Virol 18: 159–175.
61. Stephenson ST, Bostik P, Song B, Rajan D, Bhimani S, et al. (2010) Distinct host
cell proteins incorporated by SIV replicating in CD4+ T cells from natural
disease resistant versus non-natural disease susceptible hosts. Retrovirology 7:
107.
62. Del Portillo A, Tripodi J, Najfeld V, Wodarz D, Levy DN, et al. (2011)
Multiploid Inheritance of HIV-1 during Cell-to-Cell Infection. J Virol 85:
7169–7176.
Dlg1 in VS Formation and HIV-1 Transmission
PLoS ONE | www.plosone.org 14 January 2012 | Volume 7 | Issue 1 | e30130